{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:39:06Z","timestamp":1790897946724,"version":"4.1.0"},"reference-count":42,"publisher":"National Academy of Sciences","issue":"51","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2009,12,22]]},"abstract":"<jats:p>Sotos syndrome is an autosomal dominant condition characterized by overgrowth resulting in tall stature and macrocephaly, together with an increased risk of tumorigenesis. The disease is caused by loss-of-function mutations and deletions of the nuclear receptor SET domain containing protein-1 (NSD1) gene, which encodes a histone methyltransferase involved in chromatin regulation. However, despite its causal role in Sotos syndrome and the typical accelerated growth of these patients, little is known about the putative contribution of NSD1 to human sporadic malignancies. Here, we report that NSD1 function is abrogated in human neuroblastoma and glioma cells by transcriptional silencing associated with CpG island-promoter hypermethylation. We also demonstrate that the epigenetic inactivation of NSD1 in transformed cells leads to the specifically diminished methylation of the histone lysine residues H4-K20 and H3-K36. The described phenotype is also observed in Sotos syndrome patients with NSD1 genetic disruption. Expression microarray data from NSD1-depleted cells, followed by ChIP analysis, revealed that the oncogene MEIS1 is one of the main NSD1 targets in neuroblastoma. Furthermore, we show that the restoration of NSD1 expression induces tumor suppressor-like features, such as reduced colony formation density and inhibition of cellular growth. Screening a large collection of different tumor types revealed that NSD1 CpG island hypermethylation was a common event in neuroblastomas and gliomas. Most importantly, NSD1 hypermethylation was a predictor of poor outcome in high-risk neuroblastoma. These findings highlight the importance of NSD1 epigenetic inactivation in neuroblastoma and glioma that leads to a disrupted histone methylation landscape and might have a translational value as a prognostic marker.<\/jats:p>","DOI":"10.1073\/pnas.0906831106","type":"journal-article","created":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T22:19:27Z","timestamp":1260829167000},"page":"21830-21835","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":187,"title":["Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma"],"prefix":"10.1073","volume":"106","author":[{"given":"Mar\u00eda","family":"Berdasco","sequence":"first","affiliation":[{"name":"Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08907 L'Hospitalet, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ropero","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08907 L'Hospitalet, Spain;"},{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, University of Alcala, 28801 Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Setien","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08907 L'Hospitalet, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario F.","family":"Fraga","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08907 L'Hospitalet, Spain;"},{"name":"Cancer Epigenetics Unit, Instituto Universitario de Oncolog\u00eda del Principado de Asturias, Oviedo University-Hospital Universitario Central de Asturias, 33004 Oviedo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Lapunzina","sequence":"additional","affiliation":[{"name":"Instituto de Gen\u00e9tica M\u00e9dica y Molecular, Hospital Universitario La Paz, 28050 Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gine","family":"Losson","sequence":"additional","affiliation":[{"name":"Institut de G\u00e9n\u00e9tique et de Biologie Mol\u00e9culaire et Cellulaire and Institut Clinique de la Souris, Illkirch, Strasbourg 67404, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alaminos","sequence":"additional","affiliation":[{"name":"Department of Histology, Granada University and Hospital Clinico Foundation, 18071 Granada, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Kong","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazneen","family":"Rahman","sequence":"additional","affiliation":[{"name":"Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[{"name":"Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08907 L'Hospitalet, Spain;"},{"name":"Institucio Catalana de Recerca i Estudis Avan\u00e7ats, 08010 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2009,12,22]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201686"},{"key":"e_1_3_3_2_2","first-page":"2","article-title":"Sotos syndrome","volume":"7","author":"Baujat G","year":"2007","unstructured":"G Baujat, V Cormier-Daire, Sotos syndrome. Orphanet J Rare Dis 7, 2\u201336 (2007).","journal-title":"Orphanet J Rare Dis"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2005.04.007"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30064"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng863"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/345647"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/432082"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(01)00750-8"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg288"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1608"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(02)02141-2"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.02.020"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.10.001"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2004.06.005"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.1264"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812945106"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1279"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.01.029"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra072067"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601967"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M700271-MCP200"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(02)00924-7"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.300704"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00548-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M500796200"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.05.009"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.5.1298-1306.2002"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.12.5184-5196.2004"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.2000.6408"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(03)00087-9"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.12.3398"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01166-5"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.3.1.39"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22094"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/0008-5472.828.65.3","article-title":"CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas","volume":"65","author":"Abe M","year":"2005","unstructured":"M Abe, et al., CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res 65, 828\u2013834 (2005).","journal-title":"Cancer Res"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.05.001"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000139124"},{"key":"e_1_3_3_38_2","first-page":"4538","article-title":"Genomewide analysis of gene expression associated with MYCN in human neuroblastoma","volume":"63","author":"Alaminos M","year":"2003","unstructured":"M Alaminos, et al., Genomewide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 63, 4538\u20134546 (2003).","journal-title":"Cancer Res"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.349"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.317"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2008.07.004"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1531"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.0906831106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T18:08:26Z","timestamp":1685210906000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.0906831106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,22]]},"references-count":42,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2009,12,22]]}},"alternative-id":["10.1073\/pnas.0906831106"],"URL":"https:\/\/doi.org\/10.1073\/pnas.0906831106","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,22]]},"assertion":[{"value":"2009-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}